tiprankstipranks
Trending News
More News >

Livzon Pharmaceutical Announces Final Dividend Update for 2024

Story Highlights
Livzon Pharmaceutical Announces Final Dividend Update for 2024

Confident Investing Starts Here:

The latest update is out from Livzon Pharmaceutical Group ( (HK:1513) ).

Livzon Pharmaceutical Group Inc. has announced an update to its final cash dividend for the year ending December 31, 2024, with a declared dividend of RMB 11 per 10 shares. The dividend will be paid in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.08978, with payment scheduled for July 11, 2025. This announcement reflects Livzon’s commitment to shareholder returns and may impact investor sentiment positively, reinforcing its position in the pharmaceutical market.

The most recent analyst rating on (HK:1513) stock is a Sell with a HK$24.00 price target. To see the full list of analyst forecasts on Livzon Pharmaceutical Group stock, see the HK:1513 Stock Forecast page.

More about Livzon Pharmaceutical Group

Livzon Pharmaceutical Group Inc. operates in the pharmaceutical industry, focusing on the development, production, and sale of pharmaceutical products. The company is known for its diverse range of healthcare solutions and has a market focus that includes both domestic and international stakeholders.

Average Trading Volume: 1,156,094

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$32.44B

For detailed information about 1513 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App